Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-165458
Filing Date
2025-07-25
Accepted
2025-07-25 16:14:13
Documents
21
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d97426d10ka.htm   iXBRL 10-K/A 799624
2 EX-31.1 d97426dex311.htm EX-31.1 4216
4 GRAPHIC g97426g01a05.jpg GRAPHIC 616925
5 GRAPHIC g97426g01a06.jpg GRAPHIC 595945
6 GRAPHIC g97426g01a07.jpg GRAPHIC 37138
7 GRAPHIC g97426g01a26.jpg GRAPHIC 214947
8 GRAPHIC g97426g01b05.jpg GRAPHIC 592117
9 GRAPHIC g97426g01b06.jpg GRAPHIC 43208
10 GRAPHIC g97426g02b26.jpg GRAPHIC 211963
11 GRAPHIC g97426g03c26.jpg GRAPHIC 192757
  Complete submission text file 0001193125-25-165458.txt   7291970

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vgac-20250331.xsd EX-101.SCH 73246
23 EXTRACTED XBRL INSTANCE DOCUMENT d97426d10ka_htm.xml XML 202850
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-39587 | Film No.: 251151837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)